Winch Advisory Services’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-20
Closed -$4K 528
2021
Q2
$4K Hold
20
﹤0.01% 366
2021
Q1
$3K Hold
20
﹤0.01% 371
2020
Q4
$3K Buy
+20
New +$2.57K ﹤0.01% 356
2019
Q3
Sell
-19
Closed -$2K 448
2019
Q2
$2K Buy
+19
New +$2.45K ﹤0.01% 389

Other funds holding ALXN

Winch Advisory Services's ALXN Position: Q3 2021 in Review

Winch Advisory Services sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 20 shares — an estimated $4K sold.

Winch Advisory Services first reported a position in ALXN in Q2 2019 and held it in 4 quarters. The position peaked at $4K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Winch Advisory Services reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Winch Advisory Services sold 20 Alexion Pharmaceuticals shares in Q3 2021, an estimated $4K.
  • Winch Advisory Services first reported a position in Alexion Pharmaceuticals in Q2 2019 and held it in 4 quarters.
  • Winch Advisory Services's Alexion Pharmaceuticals position peaked at $4K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Winch Advisory Services's 13F filing for Q3 2021, filed 10 Nov 2021.